CTOR (Citius Oncology) Buyback Yield % : 0.00 (As of Dec. 15, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Citius Oncology's current buyback yield was 0.00%.

Citius Oncology Buyback Yield % Historical Data

The historical data trend for Citius Oncology's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Oncology Buyback Yield % Chart

Citius Oncology Annual Data

Trend

Sep22

Buyback Yield %

Citius Oncology Semi-Annual Data
	Sep22	Sep23
Buyback Yield %	-	-

Competitive Comparison of Citius Oncology's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Citius Oncology's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Citius Oncology's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citius Oncology's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Citius Oncology's Buyback Yield % falls into.

Citius Oncology Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Citius Oncology's Buyback Yield for the fiscal year that ended in Sep. 2022 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	0
	=	N/A%

Citius Oncology's annualized Buyback Yield for the quarter that ended in Sep. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0)	*	1	/	0
	=	N/A%

In calculating the annualized data, the Repurchase of Stock and Issuance of Stock data used here is one times the annual (Sep. 2023) data.

Citius Oncology Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Citius Oncology's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Citius Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Ave, Suite 2446, New York, NY, USA, 10170

Website

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.